Skip to content
HowShorted

CRISPR Therapeutics AG short interest in 2026

In 2026, CRISPR Therapeutics AG's disclosed short interest ran from 22.81% of shares outstanding on 15 Jan 2026 to 19.72% on 15 Sep 2026, a change of -3.09 percentage points. The year's high was 28.30% on 15 May 2026 and its low 19.39% on 14 Aug 2026, averaging 22.53% across 17 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 16.54 days on 15 May 2026. Full history: CRISPR Therapeutics AG.

Cite this page
Plain
Wikipedia
BibTeX

By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for CRISPR Therapeutics AG in 2026

2026 in figures

Start of year
22.81% (15 Jan 2026)
End of year
19.72% (15 Sep 2026)
Change
-3.09 pp
High
28.30% (15 May 2026)
Low
19.39% (14 Aug 2026)
Average
22.53%
Highest days to cover
16.54 (15 May 2026)
SEC filings marked
6

Every report in 2026

CRISPR Therapeutics AG short interest in 2026
SettlementShort interestDays to coverFilings since previous
15 Jan 202622.81%11.92
30 Jan 202622.97%12.10
13 Feb 202623.59%13.2110-K filed, results (8-K)
27 Feb 202622.46%14.31
13 Mar 202622.59%7.63
31 Mar 202623.56%13.23
15 Apr 202623.70%15.30
30 Apr 202623.31%11.91
15 May 202628.30%16.5410-Q filed, results (8-K)
29 May 202622.47%12.29
15 Jun 202627.55%16.35
30 Jun 202621.15%11.65
15 Jul 202620.54%11.56
31 Jul 202619.46%11.52
14 Aug 202619.39%15.5810-Q filed, results (8-K)
31 Aug 202619.41%10.73
15 Sep 202619.72%16.54

See also: CRISPR Therapeutics AG's full history · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.